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Abstract
Background: To evaluate the effect of probiotic chewing tablets on early childhood caries development in preschool
children living in a low socioeconomic multicultural area.
Methods: The investigation employed a randomized double-blind placebo-controlled design. The study group consisted
of 138 healthy 2-3-year-old children that were consecutively recruited after informed parental consent. After enrollment,
they were randomized to a test or a placebo group. The parents of the test group were instructed to give their child one
chewing tablet per day containing three strains of live probiotic bacteria (ProBiora3®) and the placebo group got identical
tablets without bacteria. The duration was one year and the prevalence and increment of initial and manifest caries
lesions was examined at baseline and follow-up. All parents were thoroughly instructed to brush the teeth of their
off-springs twice daily with fluoride toothpaste.
Results: The groups were balanced at baseline and the attrition rate was 20 %. Around 2/3 of the children in both
groups reported an acceptable compliance. The caries increment (Δds) was significantly lower in the test group when
compared with the placebo group, 0.2 vs. 0.8 (p < 0.05). The risk reduction was 0.47 (95 % CI 0.24–0.98) and the number
needed to treat close to five. No differences were displayed between the groups concerning presence of visible plaque
or bleeding-on-brushing. No side effects were reported.
Conclusions: The results suggested that early childhood caries development could be reduced through administration of
these probiotic chewing tablets as adjunct to daily use of fluoride toothpaste in preschool children. Further studies on a
possible dose–response relationship seem justified
Trial registration: ClinicalTrials.gov Identifier: NCT01720771. First received: October 31, 2012.
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Background
Probiotics are defined as live microorganisms that confer
a health benefit on the host when administrated in appro-
priate amounts [1]. During the last decade, the use of such
beneficial bacteria has gained interest within the dental
research community with focus on caries development,
periodontal health and halitosis [2–4]. For caries preven-
tion and root caries arrest, some studies have provided
encouraging results in children and adults [5–8], albeit
the quality of evidence still is regarded as insufficient [9].
It is generally thought that exposure to probiotic bacteria
early in life may have a greater impact on general and oral
health compared to adult regimes [10, 11]. For example, it
has been shown that administration of probiotic drops
containing strains of Lactobacillus reuteri during the first
year of life had an impact on caries prevalence and fre-
quency at the age of 9 years [12] Others have however
presented contrasting results [13]. As early childhood car-
ies is one of the most serious and costly health conditions
among young children [14], it seems important to investi-
gate novel self-administrated preventive strategies that
could be added to existing evidence-based recommenda-
tions [15]. The aim of the present study was therefore to
evaluate the effect of a probiotic chewing tablet, given as a
daily supplement after fluoride toothpaste use, on the de-
velopment of early childhood caries in preschool children
living in a multicultural low-socioeconomic area. The null
hypothesis was that the caries increment would not differ
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The study group consisted of 138 healthy children, 2–3
years of age that were invited and consecutively enrolled
after informed consent from both parents. The inclusion
criteria were i) absence of severe chronic disease or al-
lergy, and ii) ability to cooperate at a dental examination.
Exclusion criteria were a) ongoing medication with anti-
biotics, b) regular use of other probiotic products (dairy
products or other supplements), c) caries lesions with a
need for extractions and restorative care, and d) men-
tally or physically disabled children. The families had an
immigrant background and were inhabitants in Rosen-
gård, a multi-cultural low socio-economic suburban area
of Malmö, Sweden. An interpreter was used to explain
the study purpose and its procedures in cases with a lan-
guage barrier. During the study, 28 children (20.3 %)
dropped out and the main reasons were family reloca-
tion, within or outside the country, and failure to adhere
to the study protocol. Thus, the final evaluation was
made on 110 children as detailed in Fig. 1. The enroll-
ment of children started in November 2012 and the final
recordings were done in July 2014.
Study design
The investigation employed a randomized, double-blind,
placebo-controlled design with a treatment duration of
one year. The project was ethically approved by the re-
gional ethics committee in Lund, Sweden (ref nr: 2011/
530) and registered in ClinicalTrials.gov. (NCT01720771).
The primary outcome was caries increment and secondary
endpoints were presence of plaque and gingival health.
Intervention
After the baseline examination, the children were random-
ized to one of two parallel groups, test or placebo, with the
aid of computer-generated numbers (Excel randomization
tool) that were kept in sealed envelopes to ensure alloca-
tion concealment. The children of the test group received
probiotic chewing tablets containing not less than a 1 ×
108 total CFU ProBiora3® blend of three strains of probiotic
bacteria (S. uberis KJ2™, S. oralis KJ3™, S. rattus JH145™).
The parents were instructed to give their child one tablet
per day after brushing teeth. The tablets (EvoraKids) had a
wild cherry flavor and were sweetened with erythritol, a
natural low-cariogenic polylol. The placebo group received
identical chewing tables without probiotic bacteria and the
same instructions. The tablets were packed, coded and
supplied by Oragenics Inc., FL, USA. The parents were
given tablets for 3 months at the time, and asked to bring
Fig. 1 Flow chart of available, eligible and randomized children, indicating the reasons for dropping out
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back all non-used tablets to the clinical team when picking
up the next supply. The compliance was rated as “accept-
able” when ≤3 tablets per week were forgotten and as
“questionable” when this happened more frequently. In
connection with the enrolment, all parents were thor-
oughly instructed to carry out tooth brushing with a smear
layer of fluoridated toothpaste (1,100 ppm) twice a day
(morning and evening) throughout the entire study period.
The toothpaste was supplied by the investigators and
handed out at each visit. The parents were encouraged to
immediately report any possible perceived harmful effects
to the clinical staff and stop the intake.
Clinical registrations
The children were clinically examined at baseline and
after 1 year by one of two trained and calibrated dental hy-
gienists (UL and CE). Caries was visually scored on sur-
face level as “sound” (no evidence of caries), “initial” (first
visual change in enamel), “cavitated” (breakdown of en-
amel, with or without visible dentine) or “arrested” (hard
and smooth surface but whitish, brownish or black) after
drying and cleaning and expressed as decayed surfaces
(ds). Caries increment (Δds) was calculated as the differ-
ence between the follow-up scores and baseline for each
individual. No radiographs were exposed. The presence of
visible supragingival plaque on the buccal surfaces of the
upper front teeth was scored as “yes” or “no”. The gingival
condition was evaluated as “bleeding-on-brushing”; the
teeth were gently brushed by the dental hygienist with a
disposable toothbrush and any bleeding along the gingival
margin that appeared within 30 s was scored as “yes”. The
parents were asked to complete a questionnaire covering
their children’s medical history and ongoing dietary and
oral hygiene habits. The calibration was carried out imme-
diately prior to the baseline examination against a special-
ist in pediatric dentistry (“gold standard”). Thereafter, 12
randomly selected 2-year-old children were examined in-
dependently by the two clinicians. There was a perfect
inter-examiner agreement for presence of visible plaque
and bleeding after brushing while the agreement for the
caries scores was rated as good (Kappa value 0.63).
Statistical methods
All data were processed with the IBM SPSS software
(version 21.0, Chicago, IL, USA). The groups were com-
pared with the nonparametric Wilcoxon signed rank test
for continuous variables and chi-square tests for the cat-
egorical data. The absolute risk reduction (ARR) was
expressed as the control event rate minus the experi-
mental even rate and the number needed to treat as 1/
ARR. A p-value <0.05 was considered statistically signifi-
cant. The group allocation was unknown both for the
parents and the investigators and the code was disclosed
after the statistical calculations.
A power calculation was conducted for the primary out-
come based on a previous study in preschool children
from the same local community [16]. With α set at 0.05
and β = 0.2, it was estimated that approximately 70 sub-
jects in each arm would be needed to disclose a 50 % dif-
ference between the two groups. In order to adjust for an
expected attrition, the goal was to recruit a total number
of 175 subjects.
Results
The baseline characteristics of the two study groups and
the dropouts are presented in Table 1. The test and pla-
cebo groups were balanced in all aspects and the drop-
outs did not differ from those that completed the study.
The caries prevalence and increment is shown in Table 2.
The 1-year increment (Δds) was significantly lower (p <
0.05) in the test group compared with the placebo group
and the prevented fraction was 75 %. Based on the caries
Table 1 Baseline characteristics of the study group
Variable Test Placebo Dropout p
n = 54 n = 56 n = 28
Age (mean, SD) 2.4 (0.4) 2.3 (0.4) 2.5 (0.4) NS
Sex (boys/girls) 52/48 % 45/55 % 46/54 % NS
Medical problemsa, n (%) 17 (31 %) 18 (33 %) 9 (32 %) NS
Frequent sweet meals, n (%) 14 (25 %) 20 (36 %) 9 (32 %) NS
Supervised tooth brushing (2/day), n (%) 43 (80 %) 44 (79 %) 22 (78 %) NS
Supervised tooth brushing (1/day), n (%) 9 (17 %) 8 (15 %) 5 (18 %) NS
Number of erupted teeth (mean, SD) 18.9 (2.4) 18.9 (2.7) 19.2 (1.9) NS
Visible plaque (yes), n (%) 18 (34 %) 22 (40 %) 11 (41 %) NS
Bleeding after brushing (yes) 6 (11 %) 4 (7 %) 3 (11 %) NS
ds (mean, SD) 0.7 (1.4) 0.7 (1.4) 0.8 (1.7) NS
aexamples were asthma, frequent infections with antibiotic treatment, frequent diarrhea
NS no statistically significant difference
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prevalence, the absolute risk reduction was 22 % and the
number needed to treat was close to five. The majority
of the new lesions were enamel (initial) lesions but no
statistically significant differences between the groups
concerning the severity, or arrestment of lesions, were dis-
played (Table 3). An intention-to-treat analysis based on
caries increment revealed a relative risk reduction of 0.47
(95 % CI 0.24–0.98). There were no significant differences
between the test and the placebo group regarding the
prevalence of visible plaque (29 vs. 25 %) or bleeding-on-
brushing (13 vs. 10 %) at the 1-year follow-up.
The compliance was graded as acceptable among 72 %
of the children in the test group and 69 % in the placebo
group. No harmful events were reported during the
study period among those that completed the interven-
tion. No permanent restorative treatment or extractions
were carried out in any of the participants.
Discussion
To our knowledge, this is the first clinical study that dem-
onstrated a significant reduction of early childhood caries
following daily intake of oral probiotic tablets. Thus, the
null hypothesis was rejected. The findings were clearly in
agreement with some previous reports on probiotic lacto-
bacilli added to milk and served to preschool children
attending in public day care centers [5, 6]. In contrast, Tai-
pale and co-workers [17] failed to affect the caries occur-
rence in 4-year old children after administration of
probiotic bifidobacteria with a pacifier or spoon during the
first two years of life. However, the latter study was per-
formed in a low-caries population which was in contrast
to the present project. It is well known that there is a
strong link between socioeconomic status and oral health
[18] and it is a challenge to address and overcome such
inequalities, especially among young children. Therefore,
any educational, lifestyle or behavior-based initiatives to
improve oral health among disadvantaged children are im-
portant and likely beneficial for their well-being and qual-
ity of life [19]. The most important component of such
programs is without doubt daily fluoride exposure [20]
but our findings indicate that probiotic therapy can be
a valuable adjunct in order to increase the effectiveness
of the recommended and established preventive care. It
should be noted that over 94 % of the parents reported
that they helped their children with tooth brushing with
fluoride toothpaste, at least once daily, during the inter-
vention period. The fluoride exposure from diet and water
(<0.3 ppm) was however considered as low.
The mechanisms of probiotic action are not fully clear
but rely on local events, such as co-aggregation, competi-
tive inhibition and bacteriocin production as well as sys-
temic immune-based avenues [3]. For the caries disease,
the local effects seem most relevant and in animal models,
a competitive inhibition has previously been shown for S.
rattus and peroxide production for S. oralis and S. uberis
[21]. Furthermore, systematic reviews have concluded that
there is good evidence that probiotic supplements can
reduce the levels of mutans streptococci in plaque and sal-
iva [9, 22]. Such reductions have also been demonstrated
with the ProBiora3® concept [23, 24]. Our results indicated
that the intervention mainly affected the early enamel
demineralization rather than the cavitated lesions. With
the relatively small sample size and short study period in
mind, it would have been interesting to follow the impact
of an extended intervention on the caries progression.
Notably, no new children in the test group exhibited caries
lesions during the study period.
The enrollment of healthy volunteers for this project
was far from smooth and only around one fourth of the
eligible families gave their consent. Many parents hesitated
to give their children “pills” on a daily basis for a period of
one year. Furthermore, culture and language barriers did
not facilitate the recruitment process. Therefore, a certain
selection bias cannot be excluded and the external validity
for other high caries populations, or age groups, is unclear.
The parents that agreed to participate seemed highly moti-
vated for health-promoting actions and this was illustrated
by the acceptable compliance reached among the majority
of the participants. The relatively high attrition rate of
20.3 % was not unexpected given the volatile nature of the
immigrant population. It can be anticipated that the fam-
ilies that did not show up to collect new tablets failed to
follow the study protocol. The number of participants in-
dicated in the initial power calculation was not reached,
but the caries activity in this study population was some-
what higher than expected which, in part, saved the study
from being underpowered. The fact that no adverse events
were reported was encouraging and in accordance with
Table 2 Caries prevalence at baseline and 1-year caries
increment (Δds)
Variable Test (n = 54) Placebo (n = 56) p
Caries prevalence
Baseline (ds > 0), n (%) 13 (24 %) 15 (27 %) NS
Follow-up (ds > 0), n (%) 13 (24 %) 26 (47 %) <0.05
Caries increment
Δds (mean, SD) 0.2 (1.2) 0.8 (1.4) <0.05
NS no statistically significant difference
Table 3 Distribution of initial, cavitated and arrested caries
lesions at follow-up
Variable Test (n = 54) Placebo (n = 56) p
Initial 19 % 34 % NS
Cavitated 14 % 14 % NS
Arrested 11 % 7 % NS
Values in table denote the percentage of ds
NS no statistically significant difference
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the generally recognized as safe (GRAS) nature of pro-
biotic supplements. Initially, a number of children per-
ceived the tablets as “big” and “hard” and refused to take
them. In those cases, the parents were encouraged to
“crush” the tablets and give them in smaller pieces and this
recommendation was clearly helpful.
Conclusions
Within the limitations of the present study, the results
suggested that early childhood caries development could
be reduced through daily administration of these probiotic
chewing tablets as adjunct to daily use of fluoride tooth-
paste in preschool children. Therefore, further studies to
confirm these findings and clarify a possible dose–re-
sponse relationship, as well as health economic issues,
seem justified.
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